| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jan―16 |
Prevalence of COVID-19 at the Wahgnion-Gold mining site in Burkina Faso and use of RT-PCR initial cycle threshold to monitor the dynamics of SARS-CoV-2 load |
A. Cissé, M. Lingani, M. Tao, S. Nana, B. Kaboré, D. A. S. Eric, et al. (+4) A. Nassouri, S. Diagbouga, S. Bamba, Z. Tarnagda |
| 2 |
[GO] |
2025―Jan―16 |
COVID-19 and Dengue co-infection in paediatric patients: An endemic in a pandemic |
S. Pavani, M. Srinath, W. Sultana, V.S. Rani, S.F. Mehreen, V. Ravi |
| 3 |
[GO] |
2025―Jan―16 |
Comparative evaluation of automated KingFisher Flex Purification System 96 (ThermoFisher Scientific) and manual QIAamp Viral RNA Mini Kit (Qiagen) extraction methods for SARS-CoV-2 |
A. A. Zouré, T. R. Compaoré, J. A. Beré, T. Sagna, S. T. Soubeiga, C. Dabiré, et al. (+3) A. R. Nikiema, N. Barro, H. G. Ouedraogo |
| 4 |
[GO] |
2025―Jan―16 |
A one-year genomic surveillance of SARS-CoV-2 in patients from two sites in Burkina Faso |
A. Cissé, N. Gouba, M. Lingani, A. K. Ilboudo, J. B. Ouoba, C. Sawadogo, et al. (+9) G. Tarnagda, B. W. O. Kaboré, A. Gaye, E. Ouédraogo, A. Kafando, M. Savadogo, S. Gampini, M. Faye, Z. Tarnagda |
| 5 |
[GO] |
2024―Apr―05 |
COVID-19 in children aged 0-15 years seen at Amirou Bo뫊r Diallo National Hospital in Niamey, Niger, 2020-2021 |
H. Idé Amadou, Yacouba M. Mahamadou, B. Dodo, O. Boua Togola, S. Abo뫊r, A. Ousmane, et al. (+2) M. Garba, S. Mainassara |
| 6 |
[GO] |
2024―Apr―05 |
Need for standardization and compliance to treatment protocols for COVID-19 within the African Region of the World Health Organization |
W. L. Fuller, I. Mukankubito, J. B. Nikiema, Y. Ali Ahmed, A. O. Aboderin |
| 7 |
[GO] |
2024―Jan―18 |
<i>Falciparum</i> malaria is associated with risk markers of type 2 diabetes mellitus in individuals with or without COVID-19 exposure |
R. Adatsi, F. Pappoe, A.S. Bockarie, L. Derkyi-Kwarteng, P. Nsiah, E.W. Weyori, et al. (+4) K. Dankwa, E. Aniakwaa-Bonsu, J. Setorglo, S. Acquah |
| 8 |
[GO] |
2023―Apr―28 |
Determinants of COVID-19 vaccine acceptance amongst doctors practising in Cross River State, Nigeria |
A.A. Iwuafor, G.I. Ogban, O.I. Ita, A.B. Offiong, P.A. Owai, U.A. Udoh, D.E. Elem |
| 9 |
[GO] |
2022―Okt―26 |
A systematic review of clinical characteristics, co-morbidities and outcomes of COVID-19 in children and adolescents |
B. Adegboro, T.O. Musa-Booth, I.N. Mba, R.R. Ibrahim, N. Medugu, S.A. Abayomi, M. Babazhitsu |
| 10 |
[GO] |
2022―Jun―24 |
Evolution of SARS-CoV-2 variants: a mini-review |
T.O. Musa-Booth, B. Adegboro, N. Medugu |
| 11 |
[GO] |
2022―Feb―02 |
Predictive factors of clinical assays on hydroxychloroquine for COVID-19 mortality during the first year of the pandemic: A meta-synthesis |
M. Million, P. Dudouet, E. Chabriere, S. Cortaredona, Y. Roussel, P. Brouqui, D. Raoult |
| 12 |
[GO] |
2022―Feb―02 |
Invasive fungal infections and COVID-19: a review |
S.A. Fayemiwo, B. Adegboro |
| 13 |
[GO] |
2021―Okt―07 |
A review of the possible prognostic values of biochemical changes in patients with SARS-CoV-2 infections |
B. Adegboro, M. Babazhitsu, N.I. Mba |
| 14 |
[GO] |
2021―Okt―07 |
Pathologic changes in patients infected with SARS-CoV-2: a review |
M. Babazhitsu, O.O. Adegoke, S.A. Abayomi, B. Adegboro |
| 15 |
[GO] |
2021―Jul―05 |
Emerging infectious disease preparedness and response in healthcare: perspectives from COVID-19 and the role of College-Learnt Microbiology |
J. Tonui, W. Chepkutto, J. Rotich |
| 16 |
[GO] |
2021―Jul―05 |
Clinical symptoms and outcomes among hospitalized COVID-19 patients in Ondo State, Southwestern Nigeria |
S.O. Usman, I.I. Busari, S. Fagbemi, M.M. Adeniyi, P. Irabor, I.N. Usman, N.O. Akintayo-Usman |
| 17 |
[GO] |
2021―Apr―19 |
A call: COVID-19 research funding in Africa |
E.K. Oladipo, A.F. Ajayi, A.A. Oladipo, O.E. Ariyo, B.B. Oladipo, L.O. Ajayi, J.K. Oloke |
| 18 |
[GO] |
2021―Apr―19 |
Coronaviruses: a review of their properties and diversity |
A.A. Joseph, A.H. Fagbami |
| 19 |
[GO] |
2021―Apr―19 |
Co-infections of MERS-CoV with other respiratory viruses in Saudi Arabia |
K. Al-Quthami, W.S. Al-Waneen, B.O. Al Johnyi |
| 20 |
[GO] |
2021―Apr―09 |
Neglect of common infectious disease outbreaks during the COVID-19 pandemic: an impending crisis in Nigeria? |
T. Soyemi |
| 21 |
[GO] |
2021―Apr―09 |
Applying lessons learnt from Ebola for effective COVID-19 response in Africa |
A.E. Aiyenuro, C.O. Onyeani, N.C. Uche |
| 22 |
[GO] |
2021―Apr―09 |
A review of COVID-19 vaccines strategies and anti-vaxxers theories |
A. Adesokan, M.A. Obeid |
| 23 |
[GO] |
2021―Apr―09 |
Prognostic implication of hypocalcaemia in COVID-19: a systematic review |
T.A. Azeez, S. Lakoh, O.T. Bamidele, E. Ekhaiyeme, S.A. Nwosu |
| 24 |
[GO] |
2021―Feb―04 |
Demographic attributes of COVID-19 patients in an Infectious Disease Center of Nigeria |
G.O. Arinola, O.A. Fashina, O.C. Oluyomi Ishola, O.I. Akinbola, S.A. Akinbile, A.O. Eegunjobi, et al. (+13) M.D. Bello, F.V. Edem, S.K. Rahamon, O.I. Famuyiwa, A. J. Olaoti, O.A. Olaniyan, A.C. Oke, A. Fowotade, O. Abimbola, J.O. Johnson, O.S. Fagbemi, F. Salami, T.O. Alonge |
| 25 |
[GO] |
2021―Feb―04 |
Africa’s COVID-19 story: cheap innovation technology and climate protective effect to her rescue? |
A. Adesokan, M. MacLean |
|
